/CKMTF

CKMTF Stock - Carmat S.A.

Q: What is the analyst price target for CKMTF?

Analyst price target information is not currently available for CKMTF.

Q: What is CKMTF's market cap?

Market capitalization information is not currently available for CKMTF.

Healthcare|Medical - Devices|OTC

$12.75-50.96%

$13.25 (-50.96%) • Nov 18

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $14.03

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CKMTF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.38

52W High$12.75

52W Low$12.75

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$2.80M	$372,000	$2.24M	$9,000	$14,000
Gross Profit	$-48,345,000	$-28,447,000	$-33,387,999	$-20,079,000	$-28,284,808
Gross Margin	-1726.6%	-7647.0%	-1492.5%	-223100.0%	-202034.3%
Operating Income	$-52,500,000	$-51,922,000	$-60,408,000	$-36,411,506	$-42,393,812
Net Income	$-53,900,000	$-53,681,000	$-61,873,000	$-36,963,432	$-42,648,672
Net Margin	-1925.0%	-14430.4%	-2765.9%	-410704.8%	-304633.4%
EPS	$-2.18	$-2.37	$-3.98	$-2.85	$-3.38

Company Overview

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.

Visit Website

Earnings History & Surprises

CKMTF

Beat Rate

29%

Last 7 quarters

Avg Surprise

-50.1%

EPS vs Estimate

Beats / Misses

2/5

Last 12 quarters

Latest EPS

$-1.21

Q2 2024

EPS Surprise History

Q3 20

+7.3%

$-1.60vs$-1.73

Q1 21

No data

Q4 21

-148.3%

$-2.36vs$-0.95

Q1 22

-137.3%

$-2.25vs$-0.95

Q4 22

-60.4%

$-1.38vs$-0.86

Q4 22

+4.7%

$-1.32vs$-1.38

Q2 23

-13.4%

$-1.27vs$-1.12

Q2 24

-3.2%

$-1.21vs$-1.17

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2024	May 30, 2024	$-1.17	$-1.21	-3.2%	✗ MISS
Q2 2023	Jun 30, 2023	$-1.12	$-1.27	-13.4%	✗ MISS
Q4 2022	Dec 31, 2022	$-1.38	$-1.32	+4.7%	✓ BEAT
Q4 2022	Dec 27, 2022	$-0.86	$-1.38	-60.4%	✗ MISS
Q1 2022	Feb 16, 2022	$-0.95	$-2.25	-137.3%	✗ MISS
Q4 2021	Nov 16, 2021	$-0.95	$-2.36	-148.3%	✗ MISS
Q1 2021	Feb 10, 2021	—	$-1.75	—	—
Q3 2020	Sep 9, 2020	$-1.73	$-1.60	+7.3%	✓ BEAT
Q1 2020	Feb 12, 2020	—	$-1.92	—	—
Q3 2019	Sep 18, 2019	—	$-1.92	—	—
Q1 2019	Feb 13, 2019	—	$-2.69	—	—
Q3 2018	Sep 28, 2018	—	$-2.61	—	—
Q1 2018	Feb 13, 2018	—	$-1.90	—	—
Q3 2017	Sep 26, 2017	—	$-1.85	—	—
Q1 2017	Feb 14, 2017	—	$-2.00	—	—
Q4 2016	Dec 13, 2016	—	$-2.12	—	—
Q1 2016	Feb 29, 2016	—	$-2.09	—	—
Q4 2015	Nov 26, 2015	—	$-2.12	—	—
Q2 2015	May 10, 2015	—	$-2.71	—	—
Q4 2014	Oct 21, 2014	—	$-2.84	—	—